ISSN: 1747-4124
Journal Home
Journal Guideline
Expert Review of Gastroenterology and Hepatology Q2 Unclaimed
Expert Review of Gastroenterology and Hepatology is a journal indexed in SJR in Gastroenterology and Hepatology with an H index of 61. It has a price of 2083 €. It has an SJR impact factor of 1 and it has a best quartile of Q2. It has an SJR impact factor of 1.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
2083 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
1
SJR Impact factor61
H Index104
Total Docs (Last Year)376
Total Docs (3 years)7378
Total Refs1615
Total Cites (3 years)349
Citable Docs (3 years)3.76
Cites/Doc (2 years)70.94
Ref/DocOther journals with similar parameters
Journal of Clinical Gastroenterology Q2
Journal of Neurogastroenterology and Motility Q2
Digestive and Liver Disease Q2
Best Practice and Research in Clinical Gastroenterology Q2
Colorectal Disease Q2
Compare this journals
Aims and Scope
Best articles by citations
Non-endoscopic biopsy techniques: a review
View moreTargeting opioid signaling in Crohn's disease: new therapeutic pathways
View moreFaldaprevir for the treatment of genotype-1 hepatitis C virus
View moreRifaximin for the treatment of hepatic encephalopathy
View moreNovel avenues in immunotherapies for colorectal cancer
View moreConstipation assessment scales in adults: a literature review including the new Bowel Function Index
View moreChronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last
View moreColonoscopy: is it as effective as an advanced diagnostic tool for colorectal cancer screening?
View moreAnti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease
View moreNovel surgical options for gastroesophageal reflux disease
View moreAn evaluation of entecavir for the treatment of chronic hepatitis B infection in adults
View moreRising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean?
View moreHelicobacter pyloriand its effect on innate and adaptive immunity: new insights and vaccination strategies
View moreAchieving sustained virological response: what's the impact on further hepatitis C virus-related disease?
View moreDeterminants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis C
View moreFactors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey
View moreBiliary atresia: how medical complications and therapies impact outcome
View moreMultidisciplinary treatment of resectable rectal cancer
View moreThe validity of suspected blood indicator software in capsule endoscopy: a systematic review and meta-analysis
View moreThe management of autoimmunity in patients with cholestatic liver diseases
View moreAdvances in radiotherapy delivery for rectal cancer: a European perspective
View moreEsomeprazole for the treatment of peptic ulcer bleeding
View moreHepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management
View moreMultidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs
View more
Comments